<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(RULE 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES
13d-1(b) AND (c) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b)
HOLLIS-EDEN PHARMACEUTICALS, INC.
-----------------------------------------
(Name of Issuer)
Common Stock, par value $.01
-----------------------------------------
(Title of Class of Securities)
435902 10 1
-----------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 4 pages
<PAGE> 2
CUSIP NO. 435902 10 1 13G PAGE 2 OF 4 PAGES
--------------------- ----- -----
(1) NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
RICHARD B. HOLLIS
---------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
(B) [ ]
---------------------------------------------------------------------
(3) SEC USE ONLY
---------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES
---------------------------------------------------------------------
(5) SOLE VOTING POWER
NUMBER OF 3,244,368(1)
SHARES --------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
OWNED BY 0
EACH --------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH 3,244,368(1)
--------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
0
--------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,244,368(1)
---------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN
SHARES* [ ]
---------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
44.5%
---------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON*
IN
---------------------------------------------------------------------
(1) INCLUDES 127,777 SHARES ISSUABLE UPON EXERCISE OF OPTIONS TO PURCHASE
COMMON STOCK AND 393,250 SHARES ISSUABLE UPON EXERCISE OF WARRANTS TO PURCHASE
393,250 SHARES OF COMMON STOCK WITHIN 60 DAYS OF DECEMBER 31, 1997.
Page 2 of 4 pages
<PAGE> 3
ITEM 1(a). Name of Issuer:
Hollis-Eden Pharmaceuticals, Inc.
ITEM 1(b). Address of Issuer's Principal Executive Offices:
9333 Genesee Avenue, Suite 110
San Diego, CA 92121
ITEM 2(a). Name of Person Filing:
Richard B. Hollis
ITEM 2(b). Address of Principal Business Office or, if none, Residence:
9333 Genesee Avenue, Suite 110
San Diego, CA 92121
ITEM 2(c). Citizenship:
United States
ITEM 2(d). Title of Class of Securities:
Common Stock, par value $.01
ITEM 2(e). CUSIP Number:
435902 10 1
ITEM 3. NOT APPLICABLE.
ITEM 4. OWNERSHIP.
(a) Amount Beneficially Owned:
3,244,368 shares, including 127,777 shares issuable upon exercise
of options and 393,250 shares issuable upon exercise of warrants
outstanding within 60 days of 12/31/97.
(b) Percent of Class: 44.5%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 3,244,368
(ii) shared power to vote or to direct the vote: 0
(iii) sole power to dispose or to direct the disposition of:
3,244,368
(iv) shared power to dispose or to direct the disposition of: 0
Page 3 of 4 pages
<PAGE> 4
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities, check the
following: [ ]
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
ITEM 10. CERTIFICATION.
Not applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
-----------------------------
Date
-----------------------------
Signature
-----------------------------
Richard B. Hollis
-----------------------------
Name/Title
Page 4 of 4 pages
